Rick Geoffrion has more than 35 years of management experience in the medical device industry with more than 30 years in the cardiovascular device space.
He currently serves as the founder and Chief Executive Officer of Cyrano Therapeutics, a private company that has developed a treatment to restore the sense of smell and flavor in those who have lost it. He is also a member of the Executive Committee and the Board of Directors for MDIC, the Medical Device Innovation Consortium and Vice Chairman of The Mullings Group.
He has previously led the company foundation for four medical device companies: Mitralign (acquired by Edwards), CircuLite (acquired by HeartWare), FlowMedica (acquired by Angiodynamics) and X-Cell and guided the recapitalization and redirection of two other successful medical device companies: Impella (acquired by Abiomed) and Pathway (acquired by Bayer). He has served as the Chairman of Impella CardioSystems AG, CircuLite and FlowMedica, Inc. He has also held executive positions at Invatec (acquired by Medtronic), PercuSurge (acquired by Medtronic), Boston Scientific, SciMed Life Systems (acquired by BSX), Olympus and Baxter.
“I am proud to be part of TMG 360 Media, which is at the forefront of using 21st century digital technology to short the timeline to market for medtech companies. We’re meeting a need in the industry by combining mixed media content creation and company-growth experts to ensure healthtech organizations are set-up for success, regardless of their stage of development,” he says.
He received a BSME and an MBA from the University of Connecticut. He currently resides in Jupiter, Fla.